… trials of aspirin for the primary prevention of cardiovascular disease showed little … role of
aspirin in primary prevention of cardiovascular disease, contextualising … in men at increased risk. …

… , an increased risk of major bleeding events under aspirin … from aspirin to the P2Y 12 receptor
inhibitor clopidogrel seems … an essential isoenzyme that converts clopidogrel into its active …

… aspirin antiplatelet therapy in coronary artery disease, and additionally to clopidogrel antiplatelet
therapy in peripheral arterial disease … prevention risk score (high score = higher risk of …

… was reported as low risk, some concern, or high risk. … aspirin with clopidogrel while 4
studies compared aspirin with ticagrelor. Six trials enrolled patients with coronary artery disease …

… than aspirin alone for recurrent stroke prevention with a … search for aspirin plus clopidogrel
or aspirin plus ticagrelor … of stroke, MI, or cardiovascular disease (CVD) death.A, Myocardial …

… aspirin plus either clopidogrel (stable coronary artery disease… by 12 months of aspirin alone
in the prevention of the primary … sufficient efficacy in patients at high risk of ischemic events. …

… prevention of cardiovascular disease, discontinuing aspirin while … Key exclusion criteria
included increased risk of bleeding … clopidogrel or prasugrel was used in the 8.2% of the patients …

… as clopidogrel, also have an increased risk of GIB, but by a different mechanism from aspirin,
increasing the risk … a new strategy for the secondary prevention of CHD combined with GID …

… of major bleeding to varying degrees, with ticagrelor plus aspirin associated with the highest
risk of major bleeding. The net clinical benefit favored clopidogrel or ticagrelor monotherapy…

… compared with aspirin alone, albeit with a higher risk of major bleeding … of cardiovascular
events with clopidogrel monotherapy compared with aspirin in a heterogeneous patient cohort …